I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Phase II trial of CV301 vaccine combined with atezolizumab ..:
Sonpavde, Guru P.
;
Maughan, Benjamin Louis
;
McGregor, Bradley Alexander
...
Cancer Immunology, Immunotherapy. 72 (2022) 3 - p. 775-782 , 2022
Link:
https://doi.org/10.1007/s00262-022-03274-6
RT Journal T1
Phase II trial of CV301 vaccine combined with atezolizumab in advanced urothelial carcinoma
UL https://suche.suub.uni-bremen.de/peid=cr-10.1007_s00262-022-03274-6&Exemplar=1&LAN=DE A1 Sonpavde, Guru P. A1 Maughan, Benjamin Louis A1 McGregor, Bradley Alexander A1 Wei, Xiao X. A1 Kilbridge, Kerry L. A1 Lee, Richard J. A1 Yu, Evan Y. A1 Schweizer, Michael Thomas A1 Montgomery, Robert B. A1 Cheng, Heather H. A1 Hsieh, Andrew Caleb A1 Jain, Rohit A1 Grewal, Jaspreet S. A1 Pico-Navarro, Cesar A1 Gafoor, Zarina A1 Perschy, Teresa A1 Grivas, Petros PB Springer Science and Business Media LLC YR 2022 SN 0340-7004 SN 1432-0851 JF Cancer Immunology, Immunotherapy VO 72 IS 3 SP 775 OP 782 LK http://dx.doi.org/https://doi.org/10.1007/s00262-022-03274-6 DO https://doi.org/10.1007/s00262-022-03274-6 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)